Digital PCR (dPCR) and Real-time PCR (qPCR) market is expected to value over USD 4.5 billion with a CAGR of 8% during the forecast period 2019-2026.
Digital PCR (dPCR) and Real-time (qPCR) deals with making millions of copies of a particular DNA strand or a gene by sequencing. This method is used for various purposes like research, diagnosis, forensic science, DNA fingerprinting, target-oriented treatment and so on. Such a wide range of applications increase the demand for dPCR and qPCR thus augmenting the digital PCR (dPCR) and real-time (qPCR) market growth.
The research and development sector gets massive funding from the government as well as private organizations for undertaking dPCR and qPCR studies, making it one of the factors influencing digital PCR (dPCR) and real-time (qPCR) market growth.
The development of genetic disorders like down syndrome, Parkinson's disease, grey baby syndrome, turner’s syndrome, etc. are major factors contributing to the rising market demand. Furthermore, the range of diagnostic applications of qPCR and dPCR instruments is responsible for their increasing demand in the market worldwide.
The instruments segment is anticipated to be the dominating factor in the growth of the market amongst the rest. The demand for PCR instruments in end users is high across the globe due to their efficacy, accuracy and precision, and ease of performing diagnostics and tests. Hence this is the key factor for rising growth and CAGR.
Clinical applications are further divided into infectious disease testing, oncology testing, blood screening, etc. Infectious disease testing is the key factor in positively influence market growth due to rising patient population and awareness. Such techniques are preferred more by end users as they provide accurate results and the procedures are less tedious with dPCR and qPCR methods.
Based on the end users the hospitals and diagnostic centres along with research laboratories and academic institutes are the major contributors to market growth and rise in CAGR. The research and academic sectors use qPCR and dPCR technology for further development and study, and hospitals and diagnostic centres are majority end users as they are directly associated with its applications.
North America, Europe, and the Asia Pacific are the dominating regions amongst the rest because of the rising population and the number of disease conditions. More research and development is carried out and hence demand of qPCR and dPCR market is more in these regions, resulting in large digital PCR (dPCR) and real-time (qPCR) market share.

Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3362&...
Competitive Landscape:
The key players in the market are Abbott Laboratories, Agilent Technologies, Inc, Analytik Gena AG, Becton Dickinson and Company, Biomérieux S.A. and so on.
Abbott Laboratories is one of the major companies in this market sector. It provides a range of advanced diagnostic measures like immunoassay analyzers, chromosome enumeration probe, genotyping system, qPCR system, etc. These products are in demand due to their wide applicability, quality, and precision. Hence it is anticipated to have a large share of qPCR and dPCR market across the globe.
FutureWise Key Takeaways:
• Research and development in dPCR and qPCR technology and pharmaceuticals
• Focus on new advances in dPCR and qPCR diagnostic instruments
• Commercialization of qPCR and dPCR methods
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Segmentation:
By Product and Service:
• qPCR and dPCR products and services
1. Reagents and consumables
2. Instruments
3. Software and services
By Application:
• qPCR applications and dPCR applications
1. Forensic applications
2. Research applications
3. Clinical applications
 Infectious disease testing
 Oncology testing
 Blood screening
 Transplant diagnostics
 Other applications
By End User:
• dPCR and qPCR end users:
1. Hospitals and diagnostic centres
2. Research Laboratories and Academic Institutes
3. Pharmaceutical and Biotechnology companies
4. Clinical research organizations
5. Forensic laboratories
By Region:
• North America
• Europe
• Asia pacific
• Latin America
• Middle East and Africa

Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3362&...

Objectives of the Study:
• To provide with an exhaustive analysis on the digital PCR (dPCR) and Real-time PCR (qPCR) market by product and service, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Market Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Market Estimation Methodology
2.2.1 Revenue Mapping-Based Market Estimation
2.2.2 Usage-Based Market Estimation
2.2.3 Primary Research Validation
2.3 Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations
3 Executive Summary
4 Premium Insights
4.1 Global dPCR and qPCR Market Overview
4.2 qPCR and dPCR Market, By Region, 2019 Vs.2026 (USD Million)
4.3 Global qPCR and dPCR Market Share, By Product and Service (2019)
4.4 Global qPCR Market, By Application, 2019 vs 2026 (USD Million)
4.5 Geographical Snapshot of dPCR and qPCR Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Rising Incidences of Target Infectious Diseases and Genetic Disorders
5.2.1.2 Continuous Technological Advancements in PCR Technologies
5.2.1.3 Increasing Investments, Funds, and Grants
5.2.1.4 Increasing Use of Biomarker Profiling for Disease Diagnostics
5.2.1.5 Successful Completion of the Human Genome Project
5.2.2 Key Market Restraints
5.2.2.1 High Device Costs Associated With dPCR
5.2.2.2 Technical Limitations of qPCR and dPCR Techniques
5.2.3 Key Market Opportunities
5.2.3.1 Growing Market Penetration in Emerging Countries
5.2.3.2 Shift From Plant-Derived to Genome-Based Drug Discovery
5.2.4 Key Market Challenges
5.2.4.1 Adoption and Implementation of Miqe Guidelines
5.2.5 Key Market Trends
5.2.5.1 Development of Compact, Portable, and Lab-On-Chip PCR Devices
5.2.5.2 Ongoing Technological Integration With the PCR Process
6 dPCR and qPCR Market, By Product & Service
6.1 Introduction
6.2 qPCR Products & Services
6.2.1 qPCR Reagents and Consumables
6.2.1.1 Global qPCR Reagents and Consumables Market, By Application
6.2.1.2 Global qPCR Reagents and Consumables Market, By End User
6.2.2 qPCR Instruments
6.2.2.1 Global qPCR Instruments Market, By Application
6.2.2.2 Global qPCR Instruments Market, By End User
6.2.3 qPCR Software and Services
6.2.3.1 Global qPCR Software and Services Market, By Application
6.2.3.2 Global qPCR Software and Services Market, By End User
6.3 dPCR Products & Services
6.3.1 dPCR Instruments
6.3.1.1 Global dPCR Instruments Market, By Application
6.3.1.2 Global dPCR Instruments Market, By End User
6.3.2 dPCR Reagents and Consumables
6.3.2.1 Global dPCR Reagents and Consumables Market, By Application
6.3.2.2 Global dPCR Reagents and Consumables Market, By End User
6.3.3 dPCR Software and Services
6.3.3.1 Global dPCR Software and Services Market, By Application
6.3.3.2 Global dPCR Software and Services Market, By End User
7 dPCR and qPCR Market, By Application
7.1 Introduction
7.2 qPCR Applications
7.2.1 Clinical Applications
7.2.1.1 Infectious Disease Testing
7.2.1.1.1 The Wide Availability of qPCR Assays and Kits for Infectious Disease Testing is A Key Factor Driving Market Growth
7.2.1.2 Oncology Testing
7.2.1.2.1 Advent of Alternative Diagnostic Technologies for Oncology Testing to the Key Restraining Factor
7.2.1.3 Blood Screening
7.2.1.3.1 The Advantages Offered By qPCR Such as the Elimination of Post-Amplification Processing and Easy Process Automation to Drive the Demand for qPCR Products
7.2.1.4 Transplant Diagnostics
7.2.1.4.1 Increasing Commercialization of qPCR Products for Transplant Diagnostic to Drive the Market Growth
7.2.1.5 Other Clinical Applications
7.2.2 Research Applications
7.2.2.1 Increase in Genome-Based Research Activity Boosts the Market Growth
7.2.3 Forensic Applications
7.2.3.1 Limited Adoption of qPCR in Underdeveloped and Developing Countries is Expected to Restrict the Market Growth
7.3 dPCR Applications
7.3.1 Clinical Applications
7.3.1.1 Infectious Disease Testing
7.3.1.1.1 Accuracy and Precision of dPCR Have Made It A Prominent Tool in Infectious Disease Testing
7.3.1.2 Oncology Testing
7.3.1.2.1 dPCR Plays A Vital Role in Oncology Testing and Clinical Studies
7.3.1.3 Blood Screening
7.3.1.3.1 dPCR Offers Multiple Advantages Over Traditional Techniques for Blood Screening
7.3.1.4 Transplant Diagnostics
7.3.1.4.1 Low Market Availability of dPCR Products for Transplant Diagnostics to Reflect in Small Share of This Market Segment
7.3.1.5 Other Clinical Applications
7.3.2 Research Applications
7.3.2.1 Wide Usage of dPCR in Genetic Research is the Primary Driver for Market Growth
7.3.3 Forensic Applications
7.3.3.1 The Need to Reduce the Time and Cost of Forensic Processes is A Key Factor Driving Market Growth
8 dPCR and qPCR Market, By End User
8.1 Introduction
8.2 qPCR End Users
8.2.1 Hospitals and Diagnostic Centers
8.2.2 Research Laboratories and Academic Institutes
8.2.3 Pharmaceutical and Biotechnology Companies
8.2.4 Clinical Research Organizations
8.2.5 Forensic Laboratories
8.3 dPCR End Users
8.3.1 Hospitals and Diagnostic Centers
8.3.2 Research Laboratories and Academic Institutes
8.3.3 Pharmaceutical and Biotechnology Companies
8.3.4 Clinical Research Organizations
8.3.5 Forensic Laboratories
9 dPCR and qPCR Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 US to Dominate the North American dPCR and qPCR Market in 2019
9.2.2 Canada
9.2.2.1 Government Initiatives for Supporting Genomics Research to Drive Market Growth in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Germany to Dominate the European dPCR and qPCR Market
9.3.2 UK
9.3.2.1 Growing Focus on Genomics Research to Support Market Growth in the UK
9.3.3 France
9.3.3.1 Initiatives for Developing Genomic Medicine to Support Market Growth in France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Strong Research and Healthcare Infrastructure to Support Market Growth in Japan
9.4.2 China
9.4.2.1 Healthcare Infrastructure Modernization to Support Market Growth in China
9.4.3 India
9.4.3.1 Presence of A Large Target Patient Population to Support Market Growth in India
9.4.4 Rest of APAC
9.5 Latin America
9.5.1 Brazil
9.5.1.1 Brazil Dominated the Latam Market in 2018
9.5.2 Mexico
9.5.2.1 Favorable Trade Agreements Will Support Imports and Improve the Accessibility to dPCR and qPCR Instruments in Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Low Purchasing Power of End Users and Infrastructural Limitations to Restrain Market Growth in the Mea
10 Competitive Landscape
10.1 Overview
10.2 Global Market Share Analysis
10.2.1 Global qPCR Market Share Analysis (2018)
10.2.2 Global dPCR Market Share Analysis (2018)
10.3 Competitive Scenario
10.3.1 Key Product Launches, Enhancements, and Approvals (2016–2019)
10.3.2 Key Partnerships and Collaborations (2016–2019)
10.3.3 Key Acquisitions (2016–2019)
10.3.4 Key Expansions (2016–2019)
10.4 Competitive Leadership Mapping
10.4.1 Competitive Leadership Mapping: Major Market Players (2018)
10.4.1.1 Visionary Leaders
10.4.1.2 Innovators
10.4.1.3 Dynamic Differentiators
10.4.1.4 Emerging Companies
10.4.2 Competitive Leadership Mapping: Emerging Companies/SMEs/Start-Ups (2018)
10.4.2.1 Progressive Companies
10.4.2.2 Starting Blocks
10.4.2.3 Responsive Companies
10.4.2.4 Dynamic Companies
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Business Overview
11.1.2 Products Offered
11.1.3 Recent Developments .
11.2 Agilent Technologies, Inc.
11.2.1 Business Overview
11.2.2 Products and Services Offered
11.2.3 Recent Developments .
11.3 Analytik Jena AG (A Wholly Owned Subsidiary of Endress+Hauser Ag)
11.3.1 Business Overview
11.3.2 Products and Services Offered
11.3.3 Recent Developments .
11.4 Becton Dickinson and Company
11.4.1 Business Overview
11.4.2 Products and Services Offered
11.4.3 Recent Developments .
11.5 Biomérieux S.A.
11.5.1 Business Overview
11.5.2 Products and Services Offered
11.5.3 Recent Developments .
11.6 Bio-Rad Laboratories, Inc.
11.6.1 Business Overview
11.6.2 Products and Services Offered
11.6.3 Recent Developments .
11.6.4 FutureWise View
11.7 Danaher Corporation
11.7.1 Business Overview
11.7.2 Products Offered
11.7.3 Recent Developments .
11.8 Eppendorf AG
11.8.1 Business Overview
11.8.2 Products Offered
11.8.3 Recent Developments .
11.9 F. Hoffman-La Roche Ltd.
11.9.1 Business Overview
11.9.2 Products and Services Offered
11.9.3 Recent Developments .
11.10 Fluidigm Corporation
11.10.1 Business Overview
11.10.2 Products Offered
11.10.3 Recent Developments .
11.11 Merck KGaA
11.11.1 Business Overview
11.11.2 Products and Services Offered
11.11.3 Recent Developments .
11.12 Promega Corporation
11.12.1 Business Overview
11.12.2 Products and Services Offered
11.12.3 Recent Developments .
11.13 Qiagen N.V.
11.13.1 Business Overview
11.13.2 Products Offered
11.13.3 Recent Developments .
11.14 Takara Bio, Inc.
11.14.1 Business Overview
11.14.2 Products and Services Offered
11.14.3 Recent Developments .
11.15 Thermo Fisher Scientific, Inc.
11.15.1 Business Overview
11.15.2 Products and Services Offered
11.15.3 Recent Developments .
11.15.4 FutureWise Key Takeaways
12. Research Finding and Conclusion
13. Appendix
13.1 Research Methodology
13.2 Research Data Source

Inquire further details about this report at: [email protected]

About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com